Fujifilm Cellular Dynamics has opened its new headquarters and iPSC development and manufacturing facility in Madison, Wisconsin.
The new site is expected to quadruple the capacity for the company’s iPSC-based research products and services manufacturing footprint and expand capabilities across its research product portfolio.
As one part of a previously announced $200 million strategic investment by Fujifilm, the 175,000-square-foot building integrates cell culture manufacturing laboratories, process development laboratories, and a center of excellence for gene editing that support both research-grade iPSC products and development services for partners developing next-gen cell therapies.
Fujifilm Cellular Dynamics is part of the Fujifilm Life Sciences Group, which also includes Fujifilm Biosciences, Fujifilm Biotechnologies, Fujifilm Wako Pure Chemical Corporation and Fujifilm Toyama Chemical Co.
Subscribe to our e-Newsletters
Stay up to date with news, articles and insights relevant to cell and gene therapy development and manufacturing. Plus, get special offers from Cell & Gene Therapy Review delivered right to your inbox!
Sign up now!